Article Details

AstraZeneca receives US priority review for asthma candidate

Retrieved on: 2021-07-08 06:43:52

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca receives US priority review for asthma candidate. View article details on hiswai:

Excerpt

AstraZeneca plc (LON:AZN) announced that an asthma treatment developed with Amgen has been granted priority review in the US. Tezepelumab ...

Article found on: www.proactiveinvestors.co.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up